Artificial Intelligence in Drug Discovery Market Size, Share, Growth, and Industry Analysis, By Type (Hardware,Software,Service), By Application (Early Drug Discovery,Preclinical Phase,Clinical Phase,Regulatory Approval), Regional Insights and Forecast to 2035
Detailed TOC of Global Artificial Intelligence in Drug Discovery Market Research Report 2024
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Artificial Intelligence in Drug Discovery Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Hardware
1.2.3 Software
1.2.4 Service
1.3 Market by Application
1.3.1 Global Artificial Intelligence in Drug Discovery Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Early Drug Discovery
1.3.3 Preclinical Phase
1.3.4 Clinical Phase
1.3.5 Regulatory Approval
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Artificial Intelligence in Drug Discovery Market Perspective (2019-2030)
2.2 Artificial Intelligence in Drug Discovery Growth Trends by Region
2.2.1 Global Artificial Intelligence in Drug Discovery Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Artificial Intelligence in Drug Discovery Historic Market Size by Region (2019-2024)
2.2.3 Artificial Intelligence in Drug Discovery Forecasted Market Size by Region (2025-2030)
2.3 Artificial Intelligence in Drug Discovery Market Dynamics
2.3.1 Artificial Intelligence in Drug Discovery Industry Trends
2.3.2 Artificial Intelligence in Drug Discovery Market Drivers
2.3.3 Artificial Intelligence in Drug Discovery Market Challenges
2.3.4 Artificial Intelligence in Drug Discovery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Artificial Intelligence in Drug Discovery Players by Revenue
3.1.1 Global Top Artificial Intelligence in Drug Discovery Players by Revenue (2019-2024)
3.1.2 Global Artificial Intelligence in Drug Discovery Revenue Market Share by Players (2019-2024)
3.2 Global Artificial Intelligence in Drug Discovery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Artificial Intelligence in Drug Discovery Revenue
3.4 Global Artificial Intelligence in Drug Discovery Market Concentration Ratio
3.4.1 Global Artificial Intelligence in Drug Discovery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Artificial Intelligence in Drug Discovery Revenue in 2023
3.5 Artificial Intelligence in Drug Discovery Key Players Head office and Area Served
3.6 Key Players Artificial Intelligence in Drug Discovery Product Solution and Service
3.7 Date of Enter into Artificial Intelligence in Drug Discovery Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Artificial Intelligence in Drug Discovery Breakdown Data by Type
4.1 Global Artificial Intelligence in Drug Discovery Historic Market Size by Type (2019-2024)
4.2 Global Artificial Intelligence in Drug Discovery Forecasted Market Size by Type (2025-2030)
5 Artificial Intelligence in Drug Discovery Breakdown Data by Application
5.1 Global Artificial Intelligence in Drug Discovery Historic Market Size by Application (2019-2024)
5.2 Global Artificial Intelligence in Drug Discovery Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Artificial Intelligence in Drug Discovery Market Size (2019-2030)
6.2 North America Artificial Intelligence in Drug Discovery Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Artificial Intelligence in Drug Discovery Market Size by Country (2019-2024)
6.4 North America Artificial Intelligence in Drug Discovery Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Artificial Intelligence in Drug Discovery Market Size (2019-2030)
7.2 Europe Artificial Intelligence in Drug Discovery Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Artificial Intelligence in Drug Discovery Market Size by Country (2019-2024)
7.4 Europe Artificial Intelligence in Drug Discovery Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Artificial Intelligence in Drug Discovery Market Size (2019-2030)
8.2 Asia-Pacific Artificial Intelligence in Drug Discovery Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Artificial Intelligence in Drug Discovery Market Size by Region (2019-2024)
8.4 Asia-Pacific Artificial Intelligence in Drug Discovery Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Artificial Intelligence in Drug Discovery Market Size (2019-2030)
9.2 Latin America Artificial Intelligence in Drug Discovery Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Artificial Intelligence in Drug Discovery Market Size by Country (2019-2024)
9.4 Latin America Artificial Intelligence in Drug Discovery Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Artificial Intelligence in Drug Discovery Market Size (2019-2030)
10.2 Middle East & Africa Artificial Intelligence in Drug Discovery Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Artificial Intelligence in Drug Discovery Market Size by Country (2019-2024)
10.4 Middle East & Africa Artificial Intelligence in Drug Discovery Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 IBM
11.1.1 IBM Company Detail
11.1.2 IBM Business Overview
11.1.3 IBM Artificial Intelligence in Drug Discovery Introduction
11.1.4 IBM Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.1.5 IBM Recent Development
11.2 Exscientia
11.2.1 Exscientia Company Detail
11.2.2 Exscientia Business Overview
11.2.3 Exscientia Artificial Intelligence in Drug Discovery Introduction
11.2.4 Exscientia Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.2.5 Exscientia Recent Development
11.3 Google(Alphabet)
11.3.1 Google(Alphabet) Company Detail
11.3.2 Google(Alphabet) Business Overview
11.3.3 Google(Alphabet) Artificial Intelligence in Drug Discovery Introduction
11.3.4 Google(Alphabet) Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.3.5 Google(Alphabet) Recent Development
11.4 Microsoft
11.4.1 Microsoft Company Detail
11.4.2 Microsoft Business Overview
11.4.3 Microsoft Artificial Intelligence in Drug Discovery Introduction
11.4.4 Microsoft Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.4.5 Microsoft Recent Development
11.5 Atomwise
11.5.1 Atomwise Company Detail
11.5.2 Atomwise Business Overview
11.5.3 Atomwise Artificial Intelligence in Drug Discovery Introduction
11.5.4 Atomwise Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.5.5 Atomwise Recent Development
11.6 Schrodinger
11.6.1 Schrodinger Company Detail
11.6.2 Schrodinger Business Overview
11.6.3 Schrodinger Artificial Intelligence in Drug Discovery Introduction
11.6.4 Schrodinger Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.6.5 Schrodinger Recent Development
11.7 Aitia
11.7.1 Aitia Company Detail
11.7.2 Aitia Business Overview
11.7.3 Aitia Artificial Intelligence in Drug Discovery Introduction
11.7.4 Aitia Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.7.5 Aitia Recent Development
11.8 Insilico Medicine
11.8.1 Insilico Medicine Company Detail
11.8.2 Insilico Medicine Business Overview
11.8.3 Insilico Medicine Artificial Intelligence in Drug Discovery Introduction
11.8.4 Insilico Medicine Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.8.5 Insilico Medicine Recent Development
11.9 NVIDIA
11.9.1 NVIDIA Company Detail
11.9.2 NVIDIA Business Overview
11.9.3 NVIDIA Artificial Intelligence in Drug Discovery Introduction
11.9.4 NVIDIA Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.9.5 NVIDIA Recent Development
11.10 XtalPi
11.10.1 XtalPi Company Detail
11.10.2 XtalPi Business Overview
11.10.3 XtalPi Artificial Intelligence in Drug Discovery Introduction
11.10.4 XtalPi Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.10.5 XtalPi Recent Development
11.11 BPGbio
11.11.1 BPGbio Company Detail
11.11.2 BPGbio Business Overview
11.11.3 BPGbio Artificial Intelligence in Drug Discovery Introduction
11.11.4 BPGbio Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.11.5 BPGbio Recent Development
11.12 Owkin
11.12.1 Owkin Company Detail
11.12.2 Owkin Business Overview
11.12.3 Owkin Artificial Intelligence in Drug Discovery Introduction
11.12.4 Owkin Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.12.5 Owkin Recent Development
11.13 CytoReason
11.13.1 CytoReason Company Detail
11.13.2 CytoReason Business Overview
11.13.3 CytoReason Artificial Intelligence in Drug Discovery Introduction
11.13.4 CytoReason Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.13.5 CytoReason Recent Development
11.14 Deep Genomics
11.14.1 Deep Genomics Company Detail
11.14.2 Deep Genomics Business Overview
11.14.3 Deep Genomics Artificial Intelligence in Drug Discovery Introduction
11.14.4 Deep Genomics Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.14.5 Deep Genomics Recent Development
11.15 Cloud Pharmaceuticals
11.15.1 Cloud Pharmaceuticals Company Detail
11.15.2 Cloud Pharmaceuticals Business Overview
11.15.3 Cloud Pharmaceuticals Artificial Intelligence in Drug Discovery Introduction
11.15.4 Cloud Pharmaceuticals Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.15.5 Cloud Pharmaceuticals Recent Development
11.16 BenevolentAI
11.16.1 BenevolentAI Company Detail
11.16.2 BenevolentAI Business Overview
11.16.3 BenevolentAI Artificial Intelligence in Drug Discovery Introduction
11.16.4 BenevolentAI Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.16.5 BenevolentAI Recent Development
11.17 Cyclica
11.17.1 Cyclica Company Detail
11.17.2 Cyclica Business Overview
11.17.3 Cyclica Artificial Intelligence in Drug Discovery Introduction
11.17.4 Cyclica Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.17.5 Cyclica Recent Development
11.18 Verge Genomics
11.18.1 Verge Genomics Company Detail
11.18.2 Verge Genomics Business Overview
11.18.3 Verge Genomics Artificial Intelligence in Drug Discovery Introduction
11.18.4 Verge Genomics Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.18.5 Verge Genomics Recent Development
11.19 Valo Health
11.19.1 Valo Health Company Detail
11.19.2 Valo Health Business Overview
11.19.3 Valo Health Artificial Intelligence in Drug Discovery Introduction
11.19.4 Valo Health Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.19.5 Valo Health Recent Development
11.20 Envisagenics
11.20.1 Envisagenics Company Detail
11.20.2 Envisagenics Business Overview
11.20.3 Envisagenics Artificial Intelligence in Drug Discovery Introduction
11.20.4 Envisagenics Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.20.5 Envisagenics Recent Development
11.21 Euretos
11.21.1 Euretos Company Detail
11.21.2 Euretos Business Overview
11.21.3 Euretos Artificial Intelligence in Drug Discovery Introduction
11.21.4 Euretos Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.21.5 Euretos Recent Development
11.22 BioAge Labs
11.22.1 BioAge Labs Company Detail
11.22.2 BioAge Labs Business Overview
11.22.3 BioAge Labs Artificial Intelligence in Drug Discovery Introduction
11.22.4 BioAge Labs Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.22.5 BioAge Labs Recent Development
11.23 Iktos
11.23.1 Iktos Company Detail
11.23.2 Iktos Business Overview
11.23.3 Iktos Artificial Intelligence in Drug Discovery Introduction
11.23.4 Iktos Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.23.5 Iktos Recent Development
11.24 BioSymetrics
11.24.1 BioSymetrics Company Detail
11.24.2 BioSymetrics Business Overview
11.24.3 BioSymetrics Artificial Intelligence in Drug Discovery Introduction
11.24.4 BioSymetrics Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.24.5 BioSymetrics Recent Development
11.25 Evaxion Biotech
11.25.1 Evaxion Biotech Company Detail
11.25.2 Evaxion Biotech Business Overview
11.25.3 Evaxion Biotech Artificial Intelligence in Drug Discovery Introduction
11.25.4 Evaxion Biotech Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.25.5 Evaxion Biotech Recent Development
11.26 Aria Pharmaceuticals, Inc
11.26.1 Aria Pharmaceuticals, Inc Company Detail
11.26.2 Aria Pharmaceuticals, Inc Business Overview
11.26.3 Aria Pharmaceuticals, Inc Artificial Intelligence in Drug Discovery Introduction
11.26.4 Aria Pharmaceuticals, Inc Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.26.5 Aria Pharmaceuticals, Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Brief With: